{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:42:47Z","timestamp":1763142167757},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Infectious keratitis is a common ophthalmic condition in canine patients. Sequelae can include keratomalacia and corneal perforation, a vision threatening outcome. Photoactivated chromophore for keratitis \u2013 corneal cross-linking (PACK-CXL) is a non-surgical, adjunctive treatment method for infectious keratitis. The goal of this retrospective, multicenter study was to determine risk factors for treatment failure following PACK-CXL in canine patients suffering from suspected infectious keratitis. Medical records from four veterinary ophthalmology services were reviewed, and information related to patient demographics, ophthalmic findings, the PACK-CXL protocol used, and epithelialization time was collected and analyzed. Due to the potential for intervariable relationships, an additive Bayesian network (ABN) analysis was performed to evaluate these complex relationships.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Records for 671 eyes (668 dogs) were included in the analysis. Based on the ABN, in the population included here, patients who underwent an accelerated PACK-CXL protocol were less likely to experience treatment failure versus patients treated with a slow protocol. Mutual dependencies between exposure variables were identified by ABN, which would have been overlooked using classical regression. Corneal re-epithelialization time was shortened following PACK-CXL combined with topical medical therapy compared to PACK-CXL alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>No risk factors associated with treatment failure were identified in the population included in the present study. Canine patients may benefit from the use of accelerated PACK-CXL protocols, especially when combined with topical antibiotics and anti-collagenolytic therapy. The reasons for this apparent positive impact on treatment outcome remain unclear.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-023-03779-x","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T07:02:35Z","timestamp":1698908555000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of risk factors for treatment failure in canine patients undergoing photoactivated chromophore for keratitis \u2013 corneal cross-linking (PACK-CXL): a retrospective study using additive bayesian network analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"M. E.","family":"Kowalska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Crasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Famose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hartnack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Pot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"3779_CR1","volume-title":"Veterinary Ophthalmology","author":"KN Gelatt","year":"2021","unstructured":"Gelatt KN. Veterinary Ophthalmology. New York: Wiley-Blackwell; 2021."},{"key":"3779_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/vop.12027","volume":"17","author":"B Spiess","year":"2014","unstructured":"Spiess B, Pot SA, Florin M, Hafezi F. Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot study. Vet Ophthalmol. 2014;17:1\u201311.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/vop.12112","volume":"18","author":"F Famose","year":"2015","unstructured":"Famose F. Evaluation of accelerated collagen cross-linking for the treatment of melting keratitis in 10 cats. Vet Ophthalmol. 2015;18:95\u2013104.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/vop.12090","volume":"17","author":"S Pot","year":"2014","unstructured":"Pot S, Gallhoefer N, Matheis F, Voelter-Ratson, Hafezi F. Corneal collagen cross-linking as treatment for infectious and noninfectious corneal melting in cats and dogs: results of a prospective, nonrandomized, controlled trial. Vet Ophthalmol. 2014;17:250\u201360.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0052860","volume":"8","author":"S Hayes","year":"2013","unstructured":"Hayes S, Kamma-Lorger CS, Boote C, et al. The effect of riboflavin\/UVA collagen cross-linking therapy on the structure and hydrodynamic behaviour of the ungulate and rabbit corneal stroma. PLoS ONE. 2013;8:1\u201312.","journal-title":"PLoS ONE"},{"key":"3779_CR6","doi-asserted-by":"publisher","first-page":"13011","DOI":"10.1074\/jbc.M110.169813","volume":"286","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Conrad A, Conrad G. Effects of ultraviolet-A and riboflavin on interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem. 2011;286:13011\u201322.","journal-title":"J Biol Chem"},{"key":"3779_CR7","first-page":"711","volume":"15","author":"E Spoerl","year":"1999","unstructured":"Spoerl E, Seiler T. Techniques for stiffening the cornea. J Refract Surg. 1999;15:711\u20133.","journal-title":"J Refract Surg"},{"key":"3779_CR8","volume-title":"Corneal collagen cross-linking","author":"G Wollensak","year":"2013","unstructured":"Wollensak G. Fundamental principals of corneal collagen cross-linking. In: Hafezi F, Randleman J, editors. Corneal collagen cross-linking. New Jersey: Slack Inc; 2013."},{"key":"3779_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtos.2013.01.002","volume":"11","author":"F Raiskup","year":"2013","unstructured":"Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. Ocul Surf. 2013;11:65\u201374.","journal-title":"Ocul Surf"},{"key":"3779_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/01.ico.0000105827.85025.7f","volume":"23","author":"G Wollensak","year":"2004","unstructured":"Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin\/UVA. Cornea. 2004;23:503\u20137.","journal-title":"Cornea"},{"key":"3779_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/exer.1997.0410","volume":"66","author":"E Spoerl","year":"1998","unstructured":"Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97\u2013103.","journal-title":"Exp Eye Res"},{"key":"3779_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/j.jcrs.0000000000000663","volume":"47","author":"L Van Tigchelt","year":"2021","unstructured":"Van Tigchelt L, Van Eijgen J, Delbeke H. Alternative indications for corneal crosslinking. J Cataract Refract Surg. 2021;47:1360\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"3779_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jcrs.2007.12.039","volume":"34","author":"F Raiskup-Wolf","year":"2008","unstructured":"Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008;34:796\u2013801.","journal-title":"J Cataract Refract Surg"},{"key":"3779_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/02713680490513182","volume":"29","author":"E Spoerl","year":"2004","unstructured":"Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35\u201340.","journal-title":"Curr Eye Res"},{"key":"3779_CR15","first-page":"13","volume":"315","author":"N Al-Sabai","year":"2010","unstructured":"Al-Sabai N, Koppen C, Tassignon MJ. UVA\/riboflavin crosslinking as treatment for corneal melting. Bull Soc Belge Ophtalmol. 2010;315:13\u20137.","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"3779_CR16","doi-asserted-by":"crossref","unstructured":"Marquart ME, O\u2019Callaghan RJ. (2013) Infectious Keratitis: Secreted Bacterial Proteins That Mediate Corneal Damage. J Ophthalmol. 2013: p.\u00a0369094.","DOI":"10.1155\/2013\/369094"},{"issue":"11","key":"3779_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/microorganisms7110537","volume":"7","author":"ET Livingston","year":"2019","unstructured":"Livingston ET, Mursalin HM, Callegan MC. A pyrrhic victory: the PMN response to ocular bacterial Infections. Microorganisms. 2019;7(11):537.","journal-title":"Microorganisms"},{"key":"3779_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.exer.2016.10.014","volume":"153","author":"N Aldahlawi","year":"2016","unstructured":"Aldahlawi N, Hayes S, Meek K. An investigation into corneal enzymatic resistance following epithelium-off and epithelium-on corneal cross-linking protocols. Exp Eye Res. 2016;153:141\u201351.","journal-title":"Exp Eye Res"},{"key":"3779_CR19","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.jcrs.2015.10.004","volume":"41","author":"NH Aldahlawi","year":"2015","unstructured":"Aldahlawi NH, Hayes S, O\u2019Brart DPS, Meek KM. Standard versus accelerated riboflavin\u2013ultraviolet corneal collagen crosslinking: resistance against enzymatic digestion. J Cataract Refract Surg. 2015;41:1989\u201396.","journal-title":"J Cataract Refract Surg"},{"key":"3779_CR20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1167\/iovs.15-18769","volume":"57","author":"NH Aldahlawi","year":"2016","unstructured":"Aldahlawi NH, Hayes S, O\u2019Brart DPS, Akhbanbetova A, Littlechild SL, Meek KM. Enzymatic resistance of corneas crosslinked using riboflavin in conjunction with low energy, high energy, and pulsed UVA irradiation modes. Investig Opthalmology Vis Sci. 2016;57:1547\u201352.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"3779_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1167\/iovs.12-11277","volume":"54","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Mao X, Schwend T, Littlechild S, Conrad GW. Resistance of corneal RFUVA\u2013cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases. Investig Opthalmology Vis Sci. 2013;54:1014\u201325.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"3779_CR22","first-page":"1","volume":"00","author":"TP Large","year":"2022","unstructured":"Large TP, Mack S, Villiers E, Oliver J. In vitro susceptibility of canine corneal bacterial pathogens to three cross-linking protocols. Vet Ophthalmol. 2022;00:1\u20139.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR23","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/ICO.0000000000000550","volume":"34","author":"K Tal","year":"2015","unstructured":"Tal K, Gal-Or O, Pillar S, Zahavi A, Rock O, Bahar I. Efficacy of primary collagen cross-linking with photoactivated chromophore (PACK-CXL) for the treatment of Staphylococcus aureus\u2013induced corneal ulcers. Cornea. 2015;34:1281\u20136.","journal-title":"Cornea"},{"key":"3779_CR24","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1167\/iovs.07-1592","volume":"49","author":"SAR Martins","year":"2008","unstructured":"Martins SAR, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin\/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Investig Opthalmology Vis Sci. 2008;49:3402\u20138.","journal-title":"Investig Opthalmology Vis Sci"},{"key":"3779_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/ceo.12723","volume":"44","author":"K Makdoumi","year":"2016","unstructured":"Makdoumi K, Backman A. Photodynamic UVA-riboflavin bacterial elimination in antibiotic resistant bacteria. Clin Exp Ophthalmol. 2016;44:582\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"3779_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/ICO.0b013e31823f8f48","volume":"31","author":"A Panda","year":"2012","unstructured":"Panda A, Krishna SN, Kumar S. Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea. 2012;31:1210\u20133.","journal-title":"Cornea"},{"key":"3779_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1746-6148-9-128","volume":"9","author":"A Hellander-Edman","year":"2013","unstructured":"Hellander-Edman A, Makdoumi K, Mortensen J, Ekesten B. Corneal cross-linking in 9 horses with ulcerative keratitis. BMC Vet Res. 2013;9:128.","journal-title":"BMC Vet Res"},{"key":"3779_CR28","first-page":"411","volume":"66","author":"MA Babyak","year":"2004","unstructured":"Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411\u201321.","journal-title":"Psychosom Med"},{"key":"3779_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12917-019-1965-y","volume":"15","author":"S Hartnack","year":"2019","unstructured":"Hartnack S, Odoch T, Kratzer G, et al. Additive bayesian networks for antimicrobial resistance and potential risk factors in non-typhoidal Salmonella isolates from layer hens in Uganda. BMC Vet Res. 2019;15:212.","journal-title":"BMC Vet Res"},{"key":"3779_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fvets.2020.00073","volume":"7","author":"G Kratzer","year":"2020","unstructured":"Kratzer G. Bayesian network modeling applied to feline calicivirus Infection among cats in Switzerland. Front Vet Sci. 2020;7:17.","journal-title":"Front Vet Sci"},{"key":"3779_CR31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12917-021-03018-1","volume":"17","author":"E Yamaguchi","year":"2021","unstructured":"Yamaguchi E, Hayama Y, Shimizu Y, Murato Y, Sawai K, Yamamoto T. Additive bayesian network analysis of the relationship between bovine Respiratory Disease and management practices in dairy heifer calves at pre-weaning stage. BMC Vet Res. 2021;17:360.","journal-title":"BMC Vet Res"},{"key":"3779_CR32","unstructured":"Shukla, Kowalska M, Arteaga K et al. (2022) Photoactivated chromophore for keratitis \u2013 corneal cross-linking (PACK-CXL): retrospective multicenter study in canine and feline patients. Proceedings of the European College of Veterinary Ophthalmologists\u2019 Conference, Salzburg, Austria."},{"key":"3779_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67:1\u201348.","journal-title":"J Stat Softw"},{"key":"3779_CR34","unstructured":"Signorell A. (2021)Package \u201cDescTools\u201d tools for descriptive statistics. https:\/\/cran.r-project.org\/web\/packages\/DescTools\/index.html. Accessed 23 Sep 2022."},{"key":"3779_CR35","volume-title":"Ggplot2 elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. Ggplot2 elegant graphics for data analysis. New York: Springer-Verlag; 2016."},{"key":"3779_CR36","unstructured":"Wickham H. (2022) Package \u201cdplyr\u201d a grammar of data manipulation. https:\/\/dplyr.tidyverse.org\/reference\/dplyr-package.html. Accessed 23 Sep 2022."},{"key":"3779_CR37","unstructured":"Gordon M. (2022) Gmisc: Descriptive statistics, transition plots, and more. https:\/\/cran.r-project.org\/web\/packages\/Gmisc\/Gmisc.pdf. Accessed 23 Sep 2022."},{"key":"3779_CR38","unstructured":"Therneau T. (2022) A package for survival analysis in R. https:\/\/cran.r-project.org\/web\/packages\/survival\/citation.html. Accessed 23 Sep 2022."},{"key":"3779_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/bjo.83.9.1027","volume":"83","author":"N Morlet","year":"1999","unstructured":"Morlet N, Minassian D, Butcher J. Risk factors for treatment outcome of suspected microbial keratitis. Br J Ophthalmol. 1999;83:1027\u201331.","journal-title":"Br J Ophthalmol"},{"key":"3779_CR40","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/vop.12325","volume":"19","author":"KE Hindley","year":"2016","unstructured":"Hindley KE, Groth AD, King M, Graham K, Billson FM. Bacterial isolates, antimicrobial susceptibility, and clinical characteristics of bacterial keratitis in dogs presenting to referral practice in Australia. Vet Ophthalmol. 2016;19:418\u201326.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/vop.12480","volume":"21","author":"A Suter","year":"2018","unstructured":"Suter A, Voelter K, Hartnack S, Spiess BM, Pot SA. Septic keratitis in dogs, cats, and horses in Switzerland: associated bacteria and antibiotic susceptibility. Vet Ophthalmol. 2018;21:66\u201375.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1463-5224.2005.04061.x","volume":"8","author":"MR Prado","year":"2005","unstructured":"Prado MR, Rocha MFG, Brito EHS, et al. Survey of bacterial microorganisms in the conjunctival sac of clinically normal dogs and dogs with ulcerative keratitis in Fortaleza, Ceara, Brazil. Vet Ophthalmol. 2005;8:33\u20137.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1748-5827.2007.00437.x","volume":"49","author":"CT Lin","year":"2008","unstructured":"Lin CT, Petersen-Jones SM. Antibiotic susceptibility of bacteria isolated from cats with ulcerative keratitis in Taiwan. J Small Anim Pract. 2008;49:80\u20133.","journal-title":"J Small Anim Pract"},{"key":"3779_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40575-017-0045-5","volume":"4","author":"DG O\u2019Neill","year":"2017","unstructured":"O\u2019Neill DG, Lee MM, Brodbelt DC, et al. Corneal ulcerative Disease in dogs under primary veterinary care in England: epidemiology and clinical management. Canine Genet Epidemiol. 2017;4:5.","journal-title":"Canine Genet Epidemiol"},{"key":"3779_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/vop.12085","volume":"17","author":"F Famose","year":"2014","unstructured":"Famose F. Evaluation of accelerated collagen cross-linking for the treatment of melting keratitis in eight dogs. Vet Ophthalmol. 2014;17:358\u201367.","journal-title":"Vet Ophthalmol"},{"key":"3779_CR46","first-page":"1","volume":"48","author":"M Li","year":"2020","unstructured":"Li M, Yu T, Gao X, Wu XY. Accelerated corneal collagen cross-linking in clinical management of infectious keratitis. J Int Med Res. 2020;48:1\u201311.","journal-title":"J Int Med Res"},{"key":"3779_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2021.9716","volume":"21","author":"IR Barac","year":"2021","unstructured":"Barac IR, Balta G, Zemba M, et al. Accelerated vs. conventional collagen cross\u2013linking for infectious keratitis. Exp Ther Med. 2021;21:1\u20134.","journal-title":"Exp Ther Med"},{"key":"3779_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/ICO.0000000000000644","volume":"35","author":"L Papaioannou","year":"2016","unstructured":"Papaioannou L, Miligkos M, Papathanassiou M. Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea. 2016;35:62\u201371.","journal-title":"Cornea"},{"key":"3779_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40662-021-00272-0","volume":"9","author":"F Hafezi","year":"2022","unstructured":"Hafezi F, Hosny M, Shetty R, et al. PACK-CXL vs. antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: a prospective randomized phase 3 trial. Eye Vis. 2022;9:2.","journal-title":"Eye Vis"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03779-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T08:03:18Z","timestamp":1698912198000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3779"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03779-x","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study due to its retrospective nature; in addition, the owners of the patients described in this article who underwent treatment for suspected infectious keratitis, were required to sign treatment consent forms prior to treatment being administered.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}